Nootropics News Hubb
Advertisement Banner
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Neuroscience

Lysine Reduction and Cognitive Outcomes in Pyridoxine-Dependent Epilepsy: A New Approach to an Old Disease

admin by admin
December 11, 2022
in Neuroscience


The metabolic disorder, pyridoxine-dependent epilepsy (PDE), exemplifies the principle that expeditious diagnosis and implementation of a targeted therapy, in this case, pyridoxine or vitamin B6, may prevent catastrophic neurodevelopmental outcomes. Scurvy in sailors was the first disease identified as curable by ingestion of a vitamin over 300 years ago. The association between pyridoxine and early onset neonatal epileptic encephalopathy was established by a single-case report nearly 70 years ago.1 A mother’s third pregnancy led to a child successfully treated for neonatal seizures once it became apparent that vitamins ingested during gestation had relieved hyperemesis gravidarum and then neonatal seizures. This followed a prior pregnancy with a devastating neurologic outcome in an older sibling, without the benefit of vitamin trials and a diagnosis.



Source link

Previous Post

Solid-state NMR of paired helical filaments formed by the core tau fragment tau(297-391)

Next Post

131 I Love You Quotes (Short and famous love sayings for him or her)

Next Post

131 I Love You Quotes (Short and famous love sayings for him or her)

Recommended

Plant-Based Power with Steele Smiley

5 months ago

Ashwagandha: What It Is and Its Health Benefits

3 months ago

10 Successful Entrepreneurs Share How to Know You Made It

5 months ago

2023 Financial Forecast: How to Prepare for the Year Ahead

7 months ago

How to Develop a Growth Mindset

3 months ago

Global Burden of Ischemic Stroke in Young Adults in 204 Countries and Territories

4 months ago

© Nootropics News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

© 2022 Nootropics News Hubb All rights reserved.